ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 181 filers reported holding ADMA BIOLOGICS INC in Q2 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $479,209 | +33.7% | 42,863 | -21.1% | 0.00% | 0.0% |
| Q1 2024 | $358,334 | +59.4% | 54,293 | +9.2% | 0.00% | 0.0% |
| Q4 2023 | $224,748 | +49.2% | 49,723 | +18.2% | 0.00% | – |
| Q3 2023 | $150,604 | -2.3% | 42,068 | +0.7% | 0.00% | – |
| Q2 2023 | $154,161 | +16.6% | 41,778 | +4.6% | 0.00% | – |
| Q1 2023 | $132,258 | -15.2% | 39,957 | -0.6% | 0.00% | -100.0% |
| Q4 2022 | $155,929 | +73.3% | 40,188 | +8.6% | 0.00% | – |
| Q3 2022 | $90,000 | +26.8% | 37,004 | +2.3% | 0.00% | – |
| Q2 2022 | $71,000 | +91.9% | 36,170 | +78.5% | 0.00% | – |
| Q1 2022 | $37,000 | -5.1% | 20,265 | -26.5% | 0.00% | – |
| Q4 2021 | $39,000 | +25.8% | 27,576 | +56.6% | 0.00% | – |
| Q1 2021 | $31,000 | +10.7% | 17,612 | +20.6% | 0.00% | – |
| Q4 2020 | $28,000 | -45.1% | 14,603 | -31.4% | 0.00% | – |
| Q3 2020 | $51,000 | -20.3% | 21,292 | -3.1% | 0.00% | – |
| Q2 2020 | $64,000 | +82.9% | 21,978 | +82.0% | 0.00% | – |
| Q1 2020 | $35,000 | -55.7% | 12,073 | -38.6% | 0.00% | – |
| Q4 2019 | $79,000 | – | 19,652 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 33,169,604 | $53,072,000 | 0.34% |
| Clearline Capital LP | 922,517 | $1,476,000 | 0.22% |
| GSA CAPITAL PARTNERS LLP | 860,911 | $1,377,000 | 0.16% |
| Prosight Management, LP | 115,100 | $184,000 | 0.12% |
| Banco BTG Pactual S.A. | 92,500 | $148,000 | 0.10% |
| Meridian Wealth Management, LLC | 164,000 | $262,000 | 0.03% |
| Shay Capital LLC | 159,614 | $255,000 | 0.03% |
| Signature Wealth Management Partners, LLC | 10,500 | $17,000 | 0.02% |
| XTX Topco Ltd | 24,881 | $40,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 227,469 | $364,000 | 0.01% |